Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $186.9M | -- | -- | $0.76 | -- |
| 02/26/2026 | Q4 | $200.2M | -- | -- | $0.90 | -- |
| 11/06/2025 | Q3 | $182.3M | $179.5M | $0.12 | $0.65 | -$0.53 |
| 08/05/2025 | Q2 | $182.8M | $181.1M | -$0.11 | $0.71 | -$0.82 |
| 05/08/2025 | Q1 | $175.9M | $168.9M | $0.10 | $0.60 | -$0.49 |
| 02/27/2025 | Q4 | $185.4M | $187.3M | $0.33 | $0.83 | -$0.50 |
| 11/06/2024 | Q3 | $169.5M | $168.6M | -$3.11 | $0.70 | -$3.81 |
| 07/30/2024 | Q2 | $173.7M | $178M | $0.39 | $0.70 | -$0.31 |
| 05/07/2024 | Q1 | $165.7M | $167.1M | $0.19 | $0.62 | -$0.43 |
| 02/29/2024 | Q4 | $180.8M | $181.2M | $0.48 | $0.87 | -$0.39 |
| 11/02/2023 | Q3 | $172.9M | $163.9M | $0.23 | $0.78 | -$0.55 |
| 08/02/2023 | Q2 | -- | $169.5M | $0.49 | -- | -- |
| 05/03/2023 | Q1 | -- | $160.3M | -$0.43 | -- | -- |
| 02/28/2023 | Q4 | -- | $172M | -$0.22 | -- | -- |
| 11/03/2022 | Q3 | -- | $167.5M | -$0.02 | -- | -- |
| 08/03/2022 | Q2 | -- | $169.4M | $0.38 | -- | -- |
| 05/04/2022 | Q1 | -- | $158M | $0.15 | -- | -- |
| 02/24/2022 | Q4 | -- | $159.2M | -$0.12 | -- | -- |
| 11/03/2021 | Q3 | -- | $127.7M | $0.39 | -- | -- |
| 08/03/2021 | Q2 | -- | $135.6M | $0.42 | -- | -- |
| 05/04/2021 | Q1 | -- | $119M | $0.23 | -- | -- |
| 02/25/2021 | Q4 | -- | $131M | $0.32 | -- | -- |
| 10/29/2020 | Q3 | -- | $117.5M | $2.94 | -- | -- |
| 08/06/2020 | Q2 | -- | $75.5M | -$0.17 | -- | -- |
| 05/07/2020 | Q1 | -- | $105.7M | $0.19 | -- | -- |
| 02/20/2020 | Q4 | -- | $122.4M | -$0.12 | -- | -- |
| 11/07/2019 | Q3 | -- | $104.7M | -$0.15 | -- | -- |
| 08/08/2019 | Q2 | -- | $102.6M | $0.06 | -- | -- |
| 05/02/2019 | Q1 | -- | $91.3M | -$0.07 | -- | -- |
| 02/28/2019 | Q4 | -- | $95.1M | $0.20 | -- | -- |
| 11/01/2018 | Q3 | -- | $83.4M | -$0.02 | -- | -- |
| 08/02/2018 | Q2 | -- | $84.1M | $0.06 | -- | -- |
| 05/03/2018 | Q1 | -- | $74.6M | -$0.26 | -- | -- |
| 02/28/2018 | Q4 | -- | $79.1M | $0.11 | -- | -- |
| 11/08/2017 | Q3 | -- | $67.3M | -$0.19 | -- | -- |
| 08/02/2017 | Q2 | -- | $70.9M | -$0.49 | -- | -- |
| 05/04/2017 | Q1 | -- | $69.3M | -$0.52 | -- | -- |
| 03/01/2017 | Q4 | -- | $72.9M | -$0.11 | -- | -- |
| 11/02/2016 | Q3 | -- | $68.4M | -$0.59 | -- | -- |
| 08/04/2016 | Q2 | -- | $69.6M | -$0.21 | -- | -- |
| 05/02/2016 | Q1 | -- | $65.5M | -$0.10 | -- | -- |
Pacira Biosciences, Inc. reported $179.5M worth of top line sales in its most recent quarter.
Pacira Biosciences, Inc. announced earnings per share of $0.12 which represents a miss of analyst forecast a $0.65 per share.
Pacira Biosciences, Inc. reported $130.9M that represents $2.94 per share over the last quarter.
Pacira Biosciences, Inc.'s earnings are forecast to grow from -$2.15 per share to $2.95 per share next year representing an increase of 290.33%.
Pacira Biosciences, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.